TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 28 filers reported holding TALIS BIOMEDICAL CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,373 | -2.0% | 27,860 | 0.0% | 0.00% | – |
| Q1 2023 | $13,652 | +9.9% | 27,860 | 0.0% | 0.00% | – |
| Q4 2022 | $12,417 | -34.6% | 27,860 | 0.0% | 0.00% | – |
| Q3 2022 | $19,000 | -13.6% | 27,860 | 0.0% | 0.00% | – |
| Q2 2022 | $22,000 | -87.4% | 27,860 | -77.5% | 0.00% | – |
| Q1 2022 | $175,000 | -65.8% | 123,761 | -3.0% | 0.00% | – |
| Q4 2021 | $511,000 | -37.5% | 127,628 | -2.3% | 0.00% | – |
| Q3 2021 | $817,000 | -46.7% | 130,617 | -5.9% | 0.00% | – |
| Q2 2021 | $1,532,000 | -13.9% | 138,812 | +0.2% | 0.00% | – |
| Q1 2021 | $1,779,000 | – | 138,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 1,569,300 | $6,293,000 | 0.36% |
| ArrowMark Colorado Holdings LLC | 4,915,239 | $19,710,000 | 0.16% |
| Baker Brothers Advisors | 7,624,835 | $30,576,000 | 0.15% |
| Golden State Equity Partners | 22,133 | $89,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 188,269 | $755,000 | 0.02% |
| PDT Partners, LLC | 34,890 | $140,000 | 0.01% |
| PERSONAL CFO SOLUTIONS, LLC | 10,000 | $40,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,500 | $130,000 | 0.00% |
| Qube Research & Technologies Ltd | 59,161 | $237,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 78,628 | $315,000 | 0.00% |